Home › Cancro dell'esofago › Michigan › Grand Rapids
Studi clinici su Cancro dell'esofago a Grand Rapids, MI
14 studi su Cancro dell'esofago cercano partecipanti presso sedi a Grand Rapids e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
In reclutamentoFase 1
- START Midwest Cancer and Hematology Centers of W Michigan, Grand Rapids
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
In reclutamentoVolontari sani benvenuti
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
- Trinity Health Grand Rapids Hospital, Grand Rapids
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
Pan-tumor MRD Study
In reclutamentoStudio osservazionale
- The Cancer & Hematology Centers (CHC), Grand Rapids
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
In reclutamentoFase 1
- BAMF Health Inc., Grand Rapids
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
In reclutamentoFase 1
- BAMF Health Inc., Grand Rapids
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
In reclutamentoFase 1/2
- START Midwest, Grand Rapids
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
In reclutamentoStudio osservazionale
- Cancer & Hematology Centers of Western Michigan, Grand Rapids
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
In reclutamentoFase 3
- Research Site, Grand Rapids
Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
In reclutamentoFase 1/2
- The Cancer and Hematology Centers ( Site 8912), Grand Rapids
Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)
In reclutamentoFase 1/2
- The Cancer and Hematology Centers ( Site 6912), Grand Rapids
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
In reclutamentoFase 1
- START Midwest /ID# 248685, Grand Rapids
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
In reclutamentoFase 1/2
- START Midwest, Grand Rapids
64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
In reclutamentoFase 1/2
- BAMF Health, Inc., Grand Rapids
Studi su Cancro dell'esofago in altre città
- Houston, TX36 studi
- Boston, MA23 studi
- New York City, NY22 studi
- Nashville, TN19 studi
- St. Louis, MO17 studi
- Pittsburgh, PA15 studi
- Los Angeles, CA15 studi
- Baldwin Park, CA14 studi
- Philadelphia, PA13 studi
- San Antonio, TX12 studi
- Dallas, TX11 studi
- Arlington, VA11 studi
Altri studi a Grand Rapids
- Cancro del polmone non a piccole cellule44 studi
- Cancro colorettale40 studi
- Cancro (tutti i tipi)28 studi
- Cancro al seno26 studi
- Cancro ovarico24 studi
- Cancro metastatico22 studi
- Cancro alla prostata19 studi
- Cancro dell'endometrio18 studi
- Cancro dello stomaco18 studi
- Cancro pancreatico18 studi
- Melanoma17 studi
- Carcinoma a cellule squamose della testa e del collo15 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.